Literature DB >> 3889037

Counterregulatory responses to insulin-induced glucose reduction in the elderly.

G S Meneilly, K L Minaker, J B Young, L Landsberg, J W Rowe.   

Abstract

The impact of age on counterregulatory responses to moderate reductions in blood glucose induced by a constant insulin infusion (20 mU/m2 X min) was studied in normal young (n = 7; aged 20-42 yr) and old (n = 7; aged 66-77 yr) nonobese subjects. Insulin was infused until the whole blood glucose level fell to or below 60 mg/dl. This required an infusion time of 39 +/- 3 (+/- SE) min in the young and 36 +/- 3 min in the old. Mean basal glucose [young, 88 +/- 2 (+/- SE); old, 88 +/- 2 mg/dl), minimum glucose (young, 51 +/- 2; old, 54 +/- 1 mg/dl), time to nadir (young, 48 +/- 3; old, 44 +/- 3), and time to recovery were similar in both groups. Maximal (young, 40.3 +/- 2.3; old, 42.1 +/- 3.3 microU/ml) insulin levels were also similar. Basal and maximal levels of glucagon, epinephrine, and GH were similar in the two groups. Although basal norepinephrine values were higher in the old subjects (young, 243 +/- 38; old, 364 +/- 23 pg/ml; P = 0.02), increments above basal during reduction in blood glucose were not affected by age. Basal cortisol values were similar (young, 13.7 +/- 1.4; old, 14.0 +/- 0.7 micrograms/dl), but maximum cortisol responses were slightly greater in the old subjects (young, 14.6 +/- 1.0; old, 17.7 +/- 0.9 micrograms/dl; P = 0.03). These studies indicate that hormonal responses and counterregulatory efficiency during modest reductions in blood glucose are preserved in healthy elderly subjects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889037     DOI: 10.1210/jcem-61-1-178

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  1 in total

1.  Hypoglycemia unawareness in type 1 diabetes suppresses brain responses to hypoglycemia.

Authors:  Janice Jin Hwang; Lisa Parikh; Cheryl Lacadie; Dongju Seo; Wai Lam; Muhammad Hamza; Christian Schmidt; Feng Dai; Anne-Sophie Sejling; Renata Belfort-DeAguiar; R Todd Constable; Rajita Sinha; Robert Sherwin
Journal:  J Clin Invest       Date:  2018-03-05       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.